Health
14 Oct 2026
Roche Agrees to $100 Million Deal for Obesity Drug Targeting Fat Cells
The Swiss drugmaker signed an agreement to license a molecule from Rona Therapeutics that uses RNA interference to affect metabolic targets.
Read moreTopic
#RNA interference
1 story